TerrAscend (TSNDF) Other financing activities (2021 - 2026)
TerrAscend's (TSNDF) quarterly Other financing activities came in at -$200000.0 in Q1 2026, up 97.79% on a QoQ basis from -$9.1 million in Q4 2024.
TerrAscend (TSNDF) Other financing activities (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 5 years of Other financing activities data on file, last reported at -$200000.0 in Q1 2026.
- On a quarterly basis, Other financing activities changed N/A year-over-year to -$200000.0 in Q1 2026; TTM through Mar 2026 was -$9.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.0 million, up 111.38% from the prior year.
- Other financing activities for Q1 2026 stood at -$200000.0, up from -$9.1 million in the prior quarter.
- Over the last five years, Other financing activities for TSNDF reached as high as $9.5 million in Q2 2023 and fell as low as -$18.1 million in Q3 2023.
- Historically, Other financing activities has averaged -$2.4 million across 4 years, with a median of -$115000.0 in 2023.
- Across the five-year window, Other financing activities slumped 5025.0% in 2023 and surged 260.0% in 2024, its largest moves.
- Year by year, Other financing activities stood at $204000.0 in 2022, then slumped by 5025.0% to -$10.0 million in 2023, then rose by 9.84% to -$9.1 million in 2024, then jumped by 97.79% to -$200000.0 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were -$200000.0 in Q1 2026, -$9.1 million in Q4 2024, and $1.8 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -200,000.00 |
| Mar 31, 2026 | -200,000.00 |
| Dec 31, 2024 | -9.06 Mn |
| Dec 31, 2024 | -9.06 Mn |
| Sep 30, 2024 | 1.81 Mn |
| Sep 30, 2024 | 1.81 Mn |
| Jun 30, 2024 | -1.72 Mn |
| Jun 30, 2024 | -1.72 Mn |
| Mar 31, 2024 | 184,000.00 |
| Mar 31, 2024 | 184,000.00 |
| Dec 31, 2023 | -10.05 Mn |
| Dec 31, 2023 | -10.05 Mn |
| Sep 30, 2023 | -18.06 Mn |
| Sep 30, 2023 | -18.06 Mn |
| Jun 30, 2023 | 9.48 Mn |
| Jun 30, 2023 | 9.48 Mn |
| Mar 31, 2023 | -115,000.00 |
| Mar 31, 2023 | -115,000.00 |
| Dec 31, 2022 | 204,000.00 |
| Dec 31, 2022 | 204,000.00 |